The Teflon hypothesis

This scientific commentary refers to 'Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease', by Liu <i>et al</i>. (https://doi.org/10.1093/braincomms/fcad175).

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1093/braincomms/fcad203
Year: 2023
Published: —
Language: en

Article Details

Volume: 5
Issue: 4
Link Of The Paper: https://doi.org/10.1093/braincomms/fcad203

Timeline

Created:June 19, 2026

Related publications

Letter2020

Virtual reality and real-time neurofeedback functional MRI: a breakthrough in foreseeing Alzheimer’s disease?

Federica Agosta, Elisa Canu, Massimo Filippi

Article2024

Alzheimer’s Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?

Poul Flemming Høilund‐Carlsen, Abass Alavi, Rudolph J. Castellani, Rachael L. Neve, George Perry, Mona‐Elisabeth Revheim, Jorge R. Barrio

Letter2014

On the modelling of seizure dynamics

Karl Friston

Article2024

A comparative analysis of different reduced-port laparoscopic surgical procedures after non-curative endoscopic resection for early colorectal cancer

Dandan Song, Chongjie Huang, Chen Yang, Yating Shen, Changbao Liu, Zhong Lin Wang, Limiao Lin

Article2018

P1‐137: REDUCED ENTORHINAL GRAY MATTER VOLUME IN HEALTHY AMYLOID‐NEGATIVE <i>APOE‐E4</i> HOMOZYGOTES OF THE ALFA COHORT

Juan Domingo Gispert, Gemma Salvadó, Raffaele Cacciaglia, Grégory Operto, Carles Falcón, Anna Brugulat, Oriol Grau‐Rivera, Marc Suárez‐Calvet, Sebastián Morán, Manel Esteller, José Luís Molinuevo